IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. (2018)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41586-018-0266-0
PubMed Identifier: 29950727
Publication URI: http://europepmc.org/abstract/MED/29950727
Type: Journal Article/Review
Volume: 559
Parent Publication: Nature
Issue: 7714
ISSN: 0028-0836